Global Intraoperative Radiation Therapy Market
Global Intraoperative Radiation Therapy Market

Intraoperative Radiation Therapy Comprehensive Study by Type (Electron IORT, Intraoperative Brachytherapy), Application (Breast Cancer, Brain Tumor, Gastrointestinal Cancer, Head & Neck Cancer, Other Cancers), End-user (Hospitals, Ambulatory Surgery Centers, Specialty Clinics) Players and Region - Global Market Outlook to 2026

Intraoperative Radiation Therapy Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Feb 2021 Edition 243 Pages 212 Tables & Figures
Sample Report Speak with Analyst Request Discount
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Intraoperative Radiation Therapy?
Intraoperative radiation therapy (IORT) is an intensive radiation treatment that's administered into the surgical cavity at the time of the surgical removal of cancer. This therapy is used to treat cancers that are difficult to remove during surgery and when there is a concern that microscopic amounts of cancer may remain after the surgery. For IORT special type of radiation therapy machine is used that is capable of delivering the required radiation dose during the surgical procedure. Intraoperative radiation therapy is only appropriate for certain older and lower-risk breast cancer patients. It is estimated that about 43,600 women in the United States are expected to die in 2021 from breast cancer. It is the most commonly diagnosed cancer among United States women.

The market study is broken down by Type (Electron IORT and Intraoperative Brachytherapy), by Application (Breast Cancer, Brain Tumor, Gastrointestinal Cancer, Head & Neck Cancer and Other Cancers) and major geographies with country level break-up.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA estimates that Players from United States will contribute to the maximum growth of Global Intraoperative Radiation Therapy market throughout the predicted period.

Elekta AB (Sweden), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc. (United States), ZEISS Group (Germany), iCAD, Inc. (United States), Eckert & Ziegler (Germany), IntraOp Medical, Inc. (United States), Isoray, Inc. (United States), Becton, Dickinson and Company (United States), Sordina IORT Technologies (Italy), Varian Medical Systems, Inc. (United States), SeeDos Ltd. (United Kingdom), IsoAid LLC (United States), Salutaris Medical Devices (United States), Brainlab AG (Germany), Ariane Medical Systems Ltd. (United Kingdom), Panacea Medical Technologies Pvt. Ltd. (India) and RaySearch Laboratories (Sweden) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Xstrahl Medical (United Kingdom), DOSIsoft SA (France), Huiheng Medical (China), REMEDI Co., Ltd. (South Korea) and Merit Medical Systems Inc. (United States).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Intraoperative Radiation Therapy market by Type, Application and Region.

On the basis of geography, the market of Intraoperative Radiation Therapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-user, the sub-segment i.e. Hospitals will boost the Intraoperative Radiation Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.




Market Trend
  • High Demand for Effective Treatment for Cancer

Market Drivers
  • High Advantages of IORT over Conventional Radiotherapy
  • Increased Prevalence of Cancer among People Globally
  • Increased Adoption of Intraoperative Radiation Therapy

Opportunities
  • Emerging Demand from Developing Countries
  • Increased Research and Development Investments
  • Growth in the Healthcare Industry Worldwide

Restraints
  • Recurrence of Cancer After Therapy
  • Availability of Alternative Therapies
  • Pro

Challenges
  • Risk Associated with Radiations
  • Less Awareness about Cancer Treatment in Underdeveloped Countries


Key Target Audience
Intraoperative Radiation Therapy Machine Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users

About Approach
During this study the evaluation and validation of the market size is done through various sources including primary and secondary analysis. AMA Research & Media follows industrial and regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Electron IORT
  • Intraoperative Brachytherapy
By Application
  • Breast Cancer
  • Brain Tumor
  • Gastrointestinal Cancer
  • Head & Neck Cancer
  • Other Cancers
By End-user
  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Advantages of IORT over Conventional Radiotherapy
      • 3.2.2. Increased Prevalence of Cancer among People Globally
      • 3.2.3. Increased Adoption of Intraoperative Radiation Therapy
    • 3.3. Market Challenges
      • 3.3.1. Risk Associated with Radiations
      • 3.3.2. Less Awareness about Cancer Treatment in Underdeveloped Countries
    • 3.4. Market Trends
      • 3.4.1. High Demand for Effective Treatment for Cancer
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Intraoperative Radiation Therapy, by Type, Application, End-user and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Intraoperative Radiation Therapy (Value)
      • 5.2.1. Global Intraoperative Radiation Therapy by: Type (Value)
        • 5.2.1.1. Electron IORT
        • 5.2.1.2. Intraoperative Brachytherapy
      • 5.2.2. Global Intraoperative Radiation Therapy by: Application (Value)
        • 5.2.2.1. Breast Cancer
        • 5.2.2.2. Brain Tumor
        • 5.2.2.3. Gastrointestinal Cancer
        • 5.2.2.4. Head & Neck Cancer
        • 5.2.2.5. Other Cancers
      • 5.2.3. Global Intraoperative Radiation Therapy by: End-user (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Ambulatory Surgery Centers
        • 5.2.3.3. Specialty Clinics
      • 5.2.4. Global Intraoperative Radiation Therapy Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Intraoperative Radiation Therapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Elekta AB (Sweden)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. GMV Innovating Solutions (Spain)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Sensus Healthcare, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. ZEISS Group (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. ICAD, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Eckert & Ziegler (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. IntraOp Medical, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Isoray, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Becton, Dickinson and Company (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sordina IORT Technologies (Italy)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Varian Medical Systems, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. SeeDos Ltd. (United Kingdom)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. IsoAid LLC (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Salutaris Medical Devices (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Brainlab AG (Germany)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Ariane Medical Systems Ltd. (United Kingdom)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
      • 6.4.17. Panacea Medical Technologies Pvt. Ltd. (India)
        • 6.4.17.1. Business Overview
        • 6.4.17.2. Products/Services Offerings
        • 6.4.17.3. Financial Analysis
        • 6.4.17.4. SWOT Analysis
      • 6.4.18. RaySearch Laboratories (Sweden)
        • 6.4.18.1. Business Overview
        • 6.4.18.2. Products/Services Offerings
        • 6.4.18.3. Financial Analysis
        • 6.4.18.4. SWOT Analysis
  • 7. Global Intraoperative Radiation Therapy Sale, by Type, Application, End-user and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Intraoperative Radiation Therapy (Value)
      • 7.2.1. Global Intraoperative Radiation Therapy by: Type (Value)
        • 7.2.1.1. Electron IORT
        • 7.2.1.2. Intraoperative Brachytherapy
      • 7.2.2. Global Intraoperative Radiation Therapy by: Application (Value)
        • 7.2.2.1. Breast Cancer
        • 7.2.2.2. Brain Tumor
        • 7.2.2.3. Gastrointestinal Cancer
        • 7.2.2.4. Head & Neck Cancer
        • 7.2.2.5. Other Cancers
      • 7.2.3. Global Intraoperative Radiation Therapy by: End-user (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Ambulatory Surgery Centers
        • 7.2.3.3. Specialty Clinics
      • 7.2.4. Global Intraoperative Radiation Therapy Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Intraoperative Radiation Therapy: by Type(USD Million)
  • Table 2. Intraoperative Radiation Therapy Electron IORT , by Region USD Million (2015-2020)
  • Table 3. Intraoperative Radiation Therapy Intraoperative Brachytherapy , by Region USD Million (2015-2020)
  • Table 4. Intraoperative Radiation Therapy: by Application(USD Million)
  • Table 5. Intraoperative Radiation Therapy Breast Cancer , by Region USD Million (2015-2020)
  • Table 6. Intraoperative Radiation Therapy Brain Tumor , by Region USD Million (2015-2020)
  • Table 7. Intraoperative Radiation Therapy Gastrointestinal Cancer , by Region USD Million (2015-2020)
  • Table 8. Intraoperative Radiation Therapy Head & Neck Cancer , by Region USD Million (2015-2020)
  • Table 9. Intraoperative Radiation Therapy Other Cancers , by Region USD Million (2015-2020)
  • Table 10. Intraoperative Radiation Therapy: by End-user(USD Million)
  • Table 11. Intraoperative Radiation Therapy Hospitals , by Region USD Million (2015-2020)
  • Table 12. Intraoperative Radiation Therapy Ambulatory Surgery Centers , by Region USD Million (2015-2020)
  • Table 13. Intraoperative Radiation Therapy Specialty Clinics , by Region USD Million (2015-2020)
  • Table 14. South America Intraoperative Radiation Therapy, by Country USD Million (2015-2020)
  • Table 15. South America Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 16. South America Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 17. South America Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 18. Brazil Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 19. Brazil Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 20. Brazil Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 21. Argentina Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 22. Argentina Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 23. Argentina Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 24. Rest of South America Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 25. Rest of South America Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 26. Rest of South America Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 27. Asia Pacific Intraoperative Radiation Therapy, by Country USD Million (2015-2020)
  • Table 28. Asia Pacific Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 29. Asia Pacific Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 30. Asia Pacific Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 31. China Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 32. China Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 33. China Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 34. Japan Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 35. Japan Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 36. Japan Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 37. India Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 38. India Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 39. India Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 40. South Korea Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 41. South Korea Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 42. South Korea Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 43. Taiwan Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 44. Taiwan Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 45. Taiwan Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 46. Australia Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 47. Australia Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 48. Australia Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 52. Europe Intraoperative Radiation Therapy, by Country USD Million (2015-2020)
  • Table 53. Europe Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 54. Europe Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 55. Europe Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 56. Germany Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 57. Germany Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 58. Germany Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 59. France Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 60. France Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 61. France Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 62. Italy Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 63. Italy Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 64. Italy Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 65. United Kingdom Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 66. United Kingdom Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 67. United Kingdom Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 68. Netherlands Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 69. Netherlands Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 70. Netherlands Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 71. Rest of Europe Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 72. Rest of Europe Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 73. Rest of Europe Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 74. MEA Intraoperative Radiation Therapy, by Country USD Million (2015-2020)
  • Table 75. MEA Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 76. MEA Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 77. MEA Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 78. Middle East Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 79. Middle East Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 80. Middle East Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 81. Africa Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 82. Africa Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 83. Africa Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 84. North America Intraoperative Radiation Therapy, by Country USD Million (2015-2020)
  • Table 85. North America Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 86. North America Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 87. North America Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 88. United States Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 89. United States Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 90. United States Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 91. Canada Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 92. Canada Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 93. Canada Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 94. Mexico Intraoperative Radiation Therapy, by Type USD Million (2015-2020)
  • Table 95. Mexico Intraoperative Radiation Therapy, by Application USD Million (2015-2020)
  • Table 96. Mexico Intraoperative Radiation Therapy, by End-user USD Million (2015-2020)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Intraoperative Radiation Therapy: by Type(USD Million)
  • Table 116. Intraoperative Radiation Therapy Electron IORT , by Region USD Million (2021-2026)
  • Table 117. Intraoperative Radiation Therapy Intraoperative Brachytherapy , by Region USD Million (2021-2026)
  • Table 118. Intraoperative Radiation Therapy: by Application(USD Million)
  • Table 119. Intraoperative Radiation Therapy Breast Cancer , by Region USD Million (2021-2026)
  • Table 120. Intraoperative Radiation Therapy Brain Tumor , by Region USD Million (2021-2026)
  • Table 121. Intraoperative Radiation Therapy Gastrointestinal Cancer , by Region USD Million (2021-2026)
  • Table 122. Intraoperative Radiation Therapy Head & Neck Cancer , by Region USD Million (2021-2026)
  • Table 123. Intraoperative Radiation Therapy Other Cancers , by Region USD Million (2021-2026)
  • Table 124. Intraoperative Radiation Therapy: by End-user(USD Million)
  • Table 125. Intraoperative Radiation Therapy Hospitals , by Region USD Million (2021-2026)
  • Table 126. Intraoperative Radiation Therapy Ambulatory Surgery Centers , by Region USD Million (2021-2026)
  • Table 127. Intraoperative Radiation Therapy Specialty Clinics , by Region USD Million (2021-2026)
  • Table 128. South America Intraoperative Radiation Therapy, by Country USD Million (2021-2026)
  • Table 129. South America Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 130. South America Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 131. South America Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 132. Brazil Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 133. Brazil Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 134. Brazil Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 135. Argentina Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 136. Argentina Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 137. Argentina Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 138. Rest of South America Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 139. Rest of South America Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 140. Rest of South America Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 141. Asia Pacific Intraoperative Radiation Therapy, by Country USD Million (2021-2026)
  • Table 142. Asia Pacific Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 143. Asia Pacific Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 144. Asia Pacific Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 145. China Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 146. China Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 147. China Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 148. Japan Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 149. Japan Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 150. Japan Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 151. India Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 152. India Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 153. India Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 154. South Korea Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 155. South Korea Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 156. South Korea Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 157. Taiwan Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 158. Taiwan Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 159. Taiwan Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 160. Australia Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 161. Australia Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 162. Australia Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 163. Rest of Asia-Pacific Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 164. Rest of Asia-Pacific Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 165. Rest of Asia-Pacific Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 166. Europe Intraoperative Radiation Therapy, by Country USD Million (2021-2026)
  • Table 167. Europe Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 168. Europe Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 169. Europe Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 170. Germany Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 171. Germany Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 172. Germany Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 173. France Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 174. France Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 175. France Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 176. Italy Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 177. Italy Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 178. Italy Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 179. United Kingdom Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 180. United Kingdom Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 181. United Kingdom Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 182. Netherlands Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 183. Netherlands Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 184. Netherlands Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 185. Rest of Europe Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 186. Rest of Europe Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 187. Rest of Europe Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 188. MEA Intraoperative Radiation Therapy, by Country USD Million (2021-2026)
  • Table 189. MEA Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 190. MEA Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 191. MEA Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 192. Middle East Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 193. Middle East Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 194. Middle East Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 195. Africa Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 196. Africa Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 197. Africa Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 198. North America Intraoperative Radiation Therapy, by Country USD Million (2021-2026)
  • Table 199. North America Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 200. North America Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 201. North America Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 202. United States Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 203. United States Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 204. United States Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 205. Canada Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 206. Canada Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 207. Canada Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 208. Mexico Intraoperative Radiation Therapy, by Type USD Million (2021-2026)
  • Table 209. Mexico Intraoperative Radiation Therapy, by Application USD Million (2021-2026)
  • Table 210. Mexico Intraoperative Radiation Therapy, by End-user USD Million (2021-2026)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Intraoperative Radiation Therapy: by Type USD Million (2015-2020)
  • Figure 5. Global Intraoperative Radiation Therapy: by Application USD Million (2015-2020)
  • Figure 6. Global Intraoperative Radiation Therapy: by End-user USD Million (2015-2020)
  • Figure 7. South America Intraoperative Radiation Therapy Share (%), by Country
  • Figure 8. Asia Pacific Intraoperative Radiation Therapy Share (%), by Country
  • Figure 9. Europe Intraoperative Radiation Therapy Share (%), by Country
  • Figure 10. MEA Intraoperative Radiation Therapy Share (%), by Country
  • Figure 11. North America Intraoperative Radiation Therapy Share (%), by Country
  • Figure 12. Global Intraoperative Radiation Therapy share by Players 2020 (%)
  • Figure 13. Global Intraoperative Radiation Therapy share by Players (Top 3) 2020(%)
  • Figure 14. Global Intraoperative Radiation Therapy share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Elekta AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 17. Elekta AB (Sweden) Revenue: by Geography 2020
  • Figure 18. GMV Innovating Solutions (Spain) Revenue, Net Income and Gross profit
  • Figure 19. GMV Innovating Solutions (Spain) Revenue: by Geography 2020
  • Figure 20. Sensus Healthcare, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Sensus Healthcare, Inc. (United States) Revenue: by Geography 2020
  • Figure 22. ZEISS Group (Germany) Revenue, Net Income and Gross profit
  • Figure 23. ZEISS Group (Germany) Revenue: by Geography 2020
  • Figure 24. ICAD, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. ICAD, Inc. (United States) Revenue: by Geography 2020
  • Figure 26. Eckert & Ziegler (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Eckert & Ziegler (Germany) Revenue: by Geography 2020
  • Figure 28. IntraOp Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. IntraOp Medical, Inc. (United States) Revenue: by Geography 2020
  • Figure 30. Isoray, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Isoray, Inc. (United States) Revenue: by Geography 2020
  • Figure 32. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 33. Becton, Dickinson and Company (United States) Revenue: by Geography 2020
  • Figure 34. Sordina IORT Technologies (Italy) Revenue, Net Income and Gross profit
  • Figure 35. Sordina IORT Technologies (Italy) Revenue: by Geography 2020
  • Figure 36. Varian Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 37. Varian Medical Systems, Inc. (United States) Revenue: by Geography 2020
  • Figure 38. SeeDos Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 39. SeeDos Ltd. (United Kingdom) Revenue: by Geography 2020
  • Figure 40. IsoAid LLC (United States) Revenue, Net Income and Gross profit
  • Figure 41. IsoAid LLC (United States) Revenue: by Geography 2020
  • Figure 42. Salutaris Medical Devices (United States) Revenue, Net Income and Gross profit
  • Figure 43. Salutaris Medical Devices (United States) Revenue: by Geography 2020
  • Figure 44. Brainlab AG (Germany) Revenue, Net Income and Gross profit
  • Figure 45. Brainlab AG (Germany) Revenue: by Geography 2020
  • Figure 46. Ariane Medical Systems Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 47. Ariane Medical Systems Ltd. (United Kingdom) Revenue: by Geography 2020
  • Figure 48. Panacea Medical Technologies Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 49. Panacea Medical Technologies Pvt. Ltd. (India) Revenue: by Geography 2020
  • Figure 50. RaySearch Laboratories (Sweden) Revenue, Net Income and Gross profit
  • Figure 51. RaySearch Laboratories (Sweden) Revenue: by Geography 2020
  • Figure 52. Global Intraoperative Radiation Therapy: by Type USD Million (2021-2026)
  • Figure 53. Global Intraoperative Radiation Therapy: by Application USD Million (2021-2026)
  • Figure 54. Global Intraoperative Radiation Therapy: by End-user USD Million (2021-2026)
  • Figure 55. South America Intraoperative Radiation Therapy Share (%), by Country
  • Figure 56. Asia Pacific Intraoperative Radiation Therapy Share (%), by Country
  • Figure 57. Europe Intraoperative Radiation Therapy Share (%), by Country
  • Figure 58. MEA Intraoperative Radiation Therapy Share (%), by Country
  • Figure 59. North America Intraoperative Radiation Therapy Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Elekta AB (Sweden)
  • GMV Innovating Solutions (Spain)
  • Sensus Healthcare, Inc. (United States)
  • ZEISS Group (Germany)
  • iCAD, Inc. (United States)
  • Eckert & Ziegler (Germany)
  • IntraOp Medical, Inc. (United States)
  • Isoray, Inc. (United States)
  • Becton, Dickinson and Company (United States)
  • Sordina IORT Technologies (Italy)
  • Varian Medical Systems, Inc. (United States)
  • SeeDos Ltd. (United Kingdom)
  • IsoAid LLC (United States)
  • Salutaris Medical Devices (United States)
  • Brainlab AG (Germany)
  • Ariane Medical Systems Ltd. (United Kingdom)
  • Panacea Medical Technologies Pvt. Ltd. (India)
  • RaySearch Laboratories (Sweden)
Additional players considered in the study are as follows:
Xstrahl Medical (United Kingdom) , DOSIsoft SA (France) , Huiheng Medical (China) , REMEDI Co., Ltd. (South Korea) , Merit Medical Systems Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount
Slider
Slider
Slider
DOWNLOAD SAMPLE PDF

Speak with Analyst

Want to find out more about this report?

Get Free Consultation
Ask a Question!

Related Reports

OAB Treatment Comprehensive Study by Type (Lifestyle Changes, Prescription Medications, Bladder Botox Treatment, Nerve Stimulation, Surgery), Application (Hospitals, Clinics, Others), Disease (Idiopa...
OAB Treatment Comprehensive Study by Type (Lifestyle Changes, Prescription Medications, Bladder Botox Treatment, Nerve Stimulation, Surgery), Application (Hospitals, Clinics, Others), Disease (Idiopa...
$ 3800
Depth of Anesthesia Monitoring Comprehensive Study by Type (Devices, Consumables), Application (Fluid Management, Cesarean Section, Laparoscopic Surgery, Vascular Surgery, Orthopedic Surgery, Cardiol...
Depth of Anesthesia Monitoring Comprehensive Study by Type (Devices, Consumables), Application (Fluid Management, Cesarean Section, Laparoscopic Surgery, Vascular Surgery, Orthopedic Surgery, Cardiol...
$ 3800
Moyamoya disease Comprehensive Study by Type (Ischemic, Hemorrhagic, Epileptic, Other), Treatment (Non-Surgical {Anti-seizure medications, and Calcium channel blockers}, Surgical {Vascular bypass sur...
Moyamoya disease Comprehensive Study by Type (Ischemic, Hemorrhagic, Epileptic, Other), Treatment (Non-Surgical {Anti-seizure medications, and Calcium channel blockers}, Surgical {Vascular bypass sur...
$ 3800
Bacteriophages Therapy Comprehensive Study by Type (Lytic, Lysogenic), Application (Diagnostic, Antimicrobial Drug Discovery, Veterinary Medicines, Others), Treatment (Oral, External Application, Sur...
Bacteriophages Therapy Comprehensive Study by Type (Lytic, Lysogenic), Application (Diagnostic, Antimicrobial Drug Discovery, Veterinary Medicines, Others), Treatment (Oral, External Application, Sur...
$ 3800
Systemic Mycoses Comprehensive Study by Type (Paracoccidioides, Blastomyces, Histoplasma, Coccidiode), Fungi (Dermatophytes, Yeasts, Molds), Drugs (Amphotericin B, Amphotericin B Itraconazole, Amphot...
Systemic Mycoses Comprehensive Study by Type (Paracoccidioides, Blastomyces, Histoplasma, Coccidiode), Fungi (Dermatophytes, Yeasts, Molds), Drugs (Amphotericin B, Amphotericin B Itraconazole, Amphot...
$ 3800
Digital Brain Therapy Comprehensive Study by Application (Hospitals, Clinics, Others), Components (Devices (Sensors, Wearables, Monitors), Software {Cloud-baed, On-premise}), Therapy (Electroconvulsi...
Digital Brain Therapy Comprehensive Study by Application (Hospitals, Clinics, Others), Components (Devices (Sensors, Wearables, Monitors), Software {Cloud-baed, On-premise}), Therapy (Electroconvulsi...
$ 3800